Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
71
71 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- TTI-101Phase 22 trials
Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis
- VEGF antibodyPhase 22 trials
Lepu Biopharma Co., Ltd. · Hepatocellular Carcinoma, Advanced Colorectal Cancer
- WGI-0301Phase 22 trials
Zhejiang Haichang Biotech Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC), Hepato Cellular Carcinoma (HCC), Renal Cell Cancer
- atilizumabPhase 21 trial
Abbisko Therapeutics Co, Ltd · Hepatocellular Carcinoma
- AZD5851Cell TherapyPhase 21 trial
AstraZeneca · Hepatocellular Carcinoma
- AZD9793Phase 21 trial
AstraZeneca · Hepatocellular Carcinoma
- BB102Phase 21 trial
Broadenbio Ltd., Co. · Hepatocellular Carcinoma (HCC)
- BI-1910Phase 21 trial
BioInvent International AB · Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma
- CasdozokitugCHS-388Phase 21 trial
Coherus Oncology, Inc. · Hepatocellular Carcinoma
- Decoy20Phase 21 trial
Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)
- E7386Phase 21 trial
Eisai · Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular
- FB-1603Phase 21 trial
Febico Biomedical Corp. · Hepatocellular Carcinoma
- FinotonlimabPhase 21 trial
Sichuan Baili Pharmaceutical Co., Ltd. · Advanced Hepatocellular Carcinoma
- HA131Phase 21 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC)
- HLX53Phase 21 trial
Shanghai Henlius Biotech · Carcinoma, Hepatocellular
- MDSY-1240Phase 21 trial
Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic
- MIV-818Phase 21 trial
Medivir · Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases
- RYZ801Phase 21 trial
RayzeBio, Inc. · Hepatocellular Carcinoma (HCC)
- SCG101Phase 21 trial
SCG Cell Therapy Pte. Ltd. · Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent
- TB511Phase 21 trial
Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer
- VMD-102Single agentPhase 21 trial
VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.